Food and drug administration authorized Paxlovid (nirmatrelvir and ritonavir) in December 2021 for the treatment method of gentle-to-average COVID-19 in grownups and pediatric clients (12 a long time of age and older weighing at minimum 40 kg) with good success of direct SARS-CoV-2 viral screening who are also at higher possibility for progression to serious […]
